Cefodizime
From Wikipedia, the free encyclopedia
Cefodizime
|
|
Systematic (IUPAC) name | |
(6R,7R)-7-{[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2- methoxyiminoacetyl]amino}-3-{[5-(carboxymethyl)- 4-methyl-1,3-thiazol-2-yl]sulfanylmethyl}-8-oxo- 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
|
Identifiers | |
CAS number | ? |
ATC code | J01 |
PubChem | |
Chemical data | |
Formula | C20H20N6O7S4 |
Mol. mass | 584.673 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Cefodizime is a cephalosporin.
|